Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 2
1966 1
1977 1
1978 1
1984 1
1985 1
1986 4
1987 2
1989 2
1991 2
1992 4
1994 2
1995 1
1996 2
1997 2
1998 2
2000 1
2001 5
2002 2
2003 3
2004 7
2005 5
2007 2
2008 3
2009 8
2010 3
2011 2
2012 4
2013 3
2014 3
2015 7
2016 8
2017 7
2018 7
2019 5
2020 10
2021 10
2022 7
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma.
Leidner R, Crittenden M, Young K, Xiao H, Wu Y, Couey MA, Patel AA, Cheng AC, Watters AL, Bifulco C, Morris G, Rushforth L, Nemeth S, Urba WJ, Gough M, Bell RB. Leidner R, et al. Among authors: crittenden m. J Immunother Cancer. 2021 May;9(5):e002485. doi: 10.1136/jitc-2021-002485. J Immunother Cancer. 2021. PMID: 33963014 Free PMC article. Clinical Trial.
Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer.
J Gunderson A, Rajamanickam V, Bui C, Bernard B, Pucilowska J, Ballesteros-Merino C, Schmidt M, McCarty K, Philips M, Piening B, Dubay C, Medler T, Newell P, Hansen P, Tran E, Tang E, Bifulco C, Crittenden M, Gough M, Young KH. J Gunderson A, et al. Among authors: crittenden m. Oncoimmunology. 2021 Mar 17;10(1):1900635. doi: 10.1080/2162402X.2021.1900635. Oncoimmunology. 2021. PMID: 33796412 Free PMC article.
Defining Immunogenic and Radioimmunogenic Tumors.
Medler TR, Blair TC, Crittenden MR, Gough MJ. Medler TR, et al. Among authors: crittenden mr. Front Oncol. 2021 Mar 19;11:667075. doi: 10.3389/fonc.2021.667075. eCollection 2021. Front Oncol. 2021. PMID: 33816320 Free PMC article. Review.
Clinical Development of Novel Drug-Radiotherapy Combinations.
Ahmad SS, Crittenden MR, Tran PT, Kluetz PG, Blumenthal GM, Bulbeck H, Baird RD, Williams KJ, Illidge T, Hahn SM, Lawrence TS, Spears PA, Walker AJ, Sharma RA. Ahmad SS, et al. Among authors: crittenden mr. Clin Cancer Res. 2019 Mar 1;25(5):1455-1461. doi: 10.1158/1078-0432.CCR-18-2466. Epub 2018 Nov 29. Clin Cancer Res. 2019. PMID: 30498095 Free PMC article. Review.
Role of the immunosuppressive microenvironment in immunotherapy.
Tormoen GW, Crittenden MR, Gough MJ. Tormoen GW, et al. Among authors: crittenden mr. Adv Radiat Oncol. 2018 Oct 23;3(4):520-526. doi: 10.1016/j.adro.2018.08.018. eCollection 2018 Oct-Dec. Adv Radiat Oncol. 2018. PMID: 30370351 Free PMC article. Review.
Combination Immunotherapy Development in Melanoma.
Eggermont AMM, Crittenden M, Wargo J. Eggermont AMM, et al. Among authors: crittenden m. Am Soc Clin Oncol Educ Book. 2018 May 23;38:197-207. doi: 10.1200/EDBK_201131. Am Soc Clin Oncol Educ Book. 2018. PMID: 30231333 Free article. Review.
The paradox of radiation and T cells in tumors.
Gough MJ, Crittenden MR. Gough MJ, et al. Among authors: crittenden mr. Neoplasia. 2022 Sep;31:100808. doi: 10.1016/j.neo.2022.100808. Epub 2022 Jun 9. Neoplasia. 2022. PMID: 35691060 Free PMC article. Review.
Cultural Insensitivity Despite the Best Intentions.
Crittenden MD. Crittenden MD. Ann Thorac Surg. 2022 Aug;114(2):608. doi: 10.1016/j.athoracsur.2021.07.040. Epub 2021 Aug 17. Ann Thorac Surg. 2022. PMID: 34416228 Free PMC article. No abstract available.
Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial.
Yamazaki T, Gunderson AJ, Gilchrist M, Whiteford M, Kiely MX, Hayman A, O'Brien D, Ahmad R, Manchio JV, Fox N, McCarty K, Phillips M, Brosnan E, Vaccaro G, Li R, Simon M, Bernstein E, McCormick M, Yamasaki L, Wu Y, Drokin A, Carnahan T, To Y, Redmond WL, Lee B, Louie J, Hansen E, Solhjem MC, Cramer J, Urba WJ, Gough MJ, Crittenden MR, Young KH. Yamazaki T, et al. Among authors: crittenden mr. Lancet Oncol. 2022 Sep;23(9):1189-1200. doi: 10.1016/S1470-2045(22)00446-6. Epub 2022 Aug 8. Lancet Oncol. 2022. PMID: 35952709 Clinical Trial.
136 results